[article] 
inAmerican Journal of Occupational Therapy > Vol. 65/5 (septembre-octobre 2011) . - p. 579-588

Titre :	Usefulness of screening tools for predicting driving performance in people with Parkinson’s disease
Type de document :	texte imprimé
Auteurs :	Sherrilene Classen ; et al. ; D. N. LANFORD ; D. P. WITTER
Année de publication :	2011
Article en page(s) :	p. 579-588
Langues :	Anglais (eng)
Mots-clés :	Conduite automobile  Maladie Parkinson
Résumé :	OBJECTIVE. We used screening tests administered by a certified driving rehabilitation specialist and by Parkinson’s disease (PD) specialty neurologists to develop a model to predict on-road outcomes for patients with PD. METHOD. We administered a battery of screening tests to 41 patients with PD and 41 age-matched control participants before on-road testing. We used statistical models to predict actual on-road performance. RESULTS. The PD group had a higher failure rate, indicating more on-road errors. For the PD participants, the Useful Field of View (UFOV) Subtest 2 and Rapid Pace Walk were responsible for most of the variance in the on-road test. The model accurately categorized pass–fail outcomes for 81% of PD patients. CONCLUSION. Clinical screening batteries may be predictive of driving performance in PD. The UFOV Subtest 2, administered in approximately 15 min, may be the single most useful clinical test for such predictions.
Permalink :	./index.php?lvl=notice_display&id=14259

[article] Usefulness of screening tools for predicting driving performance in people with Parkinson’s disease [texte imprimé] / Sherrilene Classen ; et al. ; D. N. LANFORD ; D. P. WITTER . - 2011 . - p. 579-588.
Langues : Anglais (eng)
in American Journal of Occupational Therapy > Vol. 65/5 (septembre-octobre 2011) . - p. 579-588

Mots-clés :	Conduite automobile  Maladie Parkinson
Résumé :	OBJECTIVE. We used screening tests administered by a certified driving rehabilitation specialist and by Parkinson’s disease (PD) specialty neurologists to develop a model to predict on-road outcomes for patients with PD. METHOD. We administered a battery of screening tests to 41 patients with PD and 41 age-matched control participants before on-road testing. We used statistical models to predict actual on-road performance. RESULTS. The PD group had a higher failure rate, indicating more on-road errors. For the PD participants, the Useful Field of View (UFOV) Subtest 2 and Rapid Pace Walk were responsible for most of the variance in the on-road test. The model accurately categorized pass–fail outcomes for 81% of PD patients. CONCLUSION. Clinical screening batteries may be predictive of driving performance in PD. The UFOV Subtest 2, administered in approximately 15 min, may be the single most useful clinical test for such predictions.
Permalink :	./index.php?lvl=notice_display&id=14259